182 related articles for article (PubMed ID: 19608014)
1. Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.
Tang Q; Zhang J; Qi B; Shen C; Xie W
Arch Med Res; 2009 May; 40(4):256-63. PubMed ID: 19608014
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight protein (LMP)2/LMP7 abnormality underlies the downregulation of human leukocyte antigen class I antigen in a hepatocellular carcinoma cell line.
Shen YQ; Zhang JQ; Xia M; Miao FQ; Shan XN; Xie W
J Gastroenterol Hepatol; 2007 Jul; 22(7):1155-61. PubMed ID: 17608862
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
4. High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation.
Matsui M; Ikeda M; Akatsuka T
Biochem Biophys Res Commun; 2001 Feb; 280(4):1008-14. PubMed ID: 11162627
[TBL] [Abstract][Full Text] [Related]
5. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
6. [Human leukocyte antigen--B/C transcription in oral squamous cell carcinomas].
Zhang S; Li L; Tong M
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):44-7. PubMed ID: 12674622
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
Dutta N; Gupta A; Mazumder DN; Banerjee S
Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.
Lutz CT; Kurago ZB
Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701
[TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
12. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
Weinman EC; Roche PC; Kasperbauer JL; Cha SS; Sargent DJ; Cheville J; Murphy LM; Chen L; Wettstein PJ; Gostout B; Ferrone S; Strome SE
Cancer; 2003 May; 97(9):2203-11. PubMed ID: 12712472
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
14. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
Méndez R; Rodríguez T; Del Campo A; Monge E; Maleno I; Aptsiauri N; Jiménez P; Pedrinaci S; Pawelec G; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2008 May; 57(5):719-29. PubMed ID: 17934731
[TBL] [Abstract][Full Text] [Related]
16. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
17. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells.
Hong JS; Pai HK; Hong KO; Kim MA; Kim JH; Lee JI; Hong SP; Hong SD
J Oral Pathol Med; 2009 Feb; 38(2):214-9. PubMed ID: 18624931
[TBL] [Abstract][Full Text] [Related]
18. MICA and MICB overexpression in oral squamous cell carcinoma.
Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
20. [Human leukocyte antigen-DR expression and transcription in oral squamous cell carcinomas].
Li L; Zhang S; Tong M
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):48-51. PubMed ID: 12674623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]